PROTEIN KINASE DEGRADING AGENT, MEDICAMENT AND USE
The present invention belongs to the field of biomedical technology, and is specifically directed to a compound useful as protein kinase degrading agent, pharmaceutical composition comprising the same and the use thereof. The compound useful as protein kinase degrading agent disclosed by the present invention is a compound of general Formula (I), or a pharmaceutically acceptable salt, stereisomer, ester, prodrug, solvate, or deuterated compound thereof. The pharmaceutical composition disclosed by the present invention comprises the compound useful as protein kinase degrading agent. The present invention further discloses the pharmaceutical use of the compound useful as protein kinase degrading agent..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Europäisches Patentamt - (2024) vom: 08. Feb. Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
HE XUN [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-02-08, Last update posted on www.tib.eu: 2024-03-20, Last updated: 2024-03-29 |
|---|
| Patentnummer: |
WO2024027792 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA000260924 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA000260924 | ||
| 003 | DE-627 | ||
| 005 | 20240329160326.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240315s2024 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA000260924 | ||
| 035 | |a (EPA)WO2024027792 | ||
| 035 | |a (EPA)89750155 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a HE XUN |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a PROTEIN KINASE DEGRADING AGENT, MEDICAMENT AND USE |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2024-02-08, Last update posted on www.tib.eu: 2024-03-20, Last updated: 2024-03-29 | ||
| 520 | |a The present invention belongs to the field of biomedical technology, and is specifically directed to a compound useful as protein kinase degrading agent, pharmaceutical composition comprising the same and the use thereof. The compound useful as protein kinase degrading agent disclosed by the present invention is a compound of general Formula (I), or a pharmaceutically acceptable salt, stereisomer, ester, prodrug, solvate, or deuterated compound thereof. The pharmaceutical composition disclosed by the present invention comprises the compound useful as protein kinase degrading agent. The present invention further discloses the pharmaceutical use of the compound useful as protein kinase degrading agent. | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a JIN FENG |4 aut | |
| 700 | 0 | |a HUANG LIYE |4 aut | |
| 700 | 0 | |a ZHANG BIDONG |4 aut | |
| 700 | 0 | |a ZHANG TIANYUAN |4 aut | |
| 700 | 0 | |a GUO YUHAN |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 08. Feb. |
| 773 | 1 | 8 | |g year:2024 |g day:08 |g month:02 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/89750155/publication/WO2024027792A1?q=WO2024027792 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 08 |c 02 | ||